Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Cash from Investing Activities (2016 - 2025)

Pediatrix Medical (MD) has disclosed Cash from Investing Activities for 17 consecutive years, with -$10.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 430.55% to -$10.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$18.3 million, a 48.33% increase, with the full-year FY2025 number at -$18.3 million, up 48.33% from a year prior.
  • Cash from Investing Activities was -$10.3 million for Q4 2025 at Pediatrix Medical, down from $6.6 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $14.1 million in Q2 2021 to a low of -$41.2 million in Q3 2021.
  • A 5-year average of -$10.6 million and a median of -$10.8 million in 2022 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: tumbled 1741.34% in 2021, then surged 252.24% in 2025.
  • Pediatrix Medical's Cash from Investing Activities stood at -$15.6 million in 2021, then increased by 27.87% to -$11.2 million in 2022, then fell by 10.52% to -$12.4 million in 2023, then soared by 84.4% to -$1.9 million in 2024, then tumbled by 430.55% to -$10.3 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Cash from Investing Activities are -$10.3 million (Q4 2025), $6.6 million (Q3 2025), and -$7.2 million (Q2 2025).